Allurion Technologies (ALUR) announced a strategic distribution partnership with ProSurg Medical, a Brazilian medical device company specializing in bariatric and obesity care. The partnership will draw upon ProSurg Medical’s 30-year experience in the Brazilian market and its network spanning over 300 hospitals. Allurion stated the aim is to increase access to providers, including those offering a combination of the Allurion Program with GLP-1 therapy.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALUR:
- Allurion Technologies Delays Q3 2025 Report Filing
- Allurion Technologies Reports Q3 2025 Financial Results
- Allurion Technologies’ Earnings Call: Progress Amid Challenges
- Allurion Technologies: Strong Q3 Performance and Strategic Shifts Drive Buy Rating
- Allurion Technologies Secures $5M in New Funding